Healthcare analysts and industry groups still don’t know what to expect from the Trump administration’s plan to combat high drug prices, a week after the president announced what he deemed the “most sweeping action in history to lower the price of prescription drugs.”

Trump’s blueprint laid out a series of proposals, but details for several are sparse, and no concrete regulations have been proposed yet.